Chris Cargill appointed as President and Chief Executive Officer • Dr.

success Sosei and PharmEnable extend neurological disease drugs hunt Sosei Heptares’ President & CEO Chris

Christopher Langmead and colleagues' work on the 5-HT2C receptor as a therapeutic target for substance

Chris Langmead , Professor and Deputy Director, Neuromedicines Discovery Centre at Monash University

Chris Tate About this episode Dr. Chris Tate obtained his Ph.D. from the University of Bristol in 1989 and then moved to the University Chris also worked on the E. coli multidrug transporter EmrE and obtained both 2D and 3D crystals as well Join me to learn more about Chris’s work and his role in founding Heptares which was later acquired by Chris Tate on the web LinkedIn ResearchGate Pubmed Google Scholar Sosei Heptares Wikipedia MRC Laboratory

Chris Tate and Dr. Richard Henderson at the Laboratory of Molecular Biology in Cambridge, UK.